Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China · Delayed Price · Currency is CNY 85.48
+1.64 (1.96%)
Sep 30, 2026, 3:00 PM CST
SHA:688016 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,329 | 11,083 | 13,442 | 16,101 | 13,607 | 17,904 | |
Market Cap Growth | -21.17% | -17.55% | -16.51% | 18.33% | -24.00% | -0.98% |
Enterprise Value | 8,184 | 8,984 | 11,002 | 15,114 | 12,630 | 16,783 |
Last Close Price | 85.48 | 90.74 | 106.98 | 123.17 | 118.00 | 153.52 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.94 | 19.67 | 26.77 | 32.70 | 38.13 | 56.68 |
Forward PE | 16.42 | 16.89 | 17.88 | 23.59 | 26.68 | 46.41 |
PS Ratio | 7.22 | 8.21 | 11.14 | 13.56 | 15.18 | 26.15 |
PB Ratio | 2.42 | 2.70 | 3.52 | 4.17 | 7.81 | 11.76 |
P/TBV Ratio | 3.06 | 3.47 | 4.61 | 4.43 | 9.07 | 12.62 |
P/FCF Ratio | 35.57 | 41.04 | 83.52 | 43.75 | 342.02 | 84.98 |
P/OCF Ratio | 18.99 | 19.34 | 35.98 | 28.84 | 40.77 | 59.63 |
PEG Ratio | - | 1.08 | 1.08 | 1.08 | 4.36 | 4.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.72 | 6.65 | 9.12 | 12.73 | 14.09 | 24.51 |
EV/EBITDA Ratio | 12.36 | 13.86 | 19.64 | 27.07 | 31.90 | 50.34 |
EV/EBIT Ratio | 13.90 | 15.37 | 21.07 | 28.28 | 33.84 | 52.78 |
EV/FCF Ratio | 28.18 | 33.27 | 68.36 | 41.07 | 317.48 | 79.66 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 |
Debt / EBITDA Ratio | 0.03 | 0.02 | 0.07 | 0.06 | 0.10 | 0.13 |
Debt / FCF Ratio | 0.06 | 0.06 | 0.25 | 0.10 | 1.03 | 0.22 |
Net Debt / Equity Ratio | -0.51 | -0.51 | -0.56 | -0.76 | -0.54 | -0.79 |
Net Debt / EBITDA Ratio | -3.32 | -3.22 | -3.80 | -5.25 | -2.36 | -3.59 |
Net Debt / FCF Ratio | -7.45 | -7.73 | -13.23 | -7.96 | -23.52 | -5.68 |
Asset Turnover | 0.30 | 0.30 | 0.28 | 0.38 | 0.48 | 0.44 |
Inventory Turnover | 1.57 | 1.48 | 1.38 | 1.56 | 1.71 | 1.63 |
Quick Ratio | 4.80 | 6.08 | 7.15 | 9.96 | 5.90 | 8.13 |
Current Ratio | 5.42 | 6.85 | 8.08 | 10.76 | 6.93 | 9.00 |
Return on Equity (ROE) | 13.48% | 14.01% | 12.82% | 17.38% | 21.57% | 22.75% |
Return on Assets (ROA) | 7.70% | 8.18% | 7.65% | 10.70% | 12.45% | 12.70% |
Return on Invested Capital (ROIC) | 23.27% | 26.80% | 30.06% | 52.31% | 56.12% | 108.65% |
Return on Capital Employed (ROCE) | 13.40% | 13.80% | 13.20% | 13.60% | 20.60% | 20.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.53% | 5.08% | 3.74% | 3.06% | 2.62% | 1.76% |
FCF Yield | 2.81% | 2.44% | 1.20% | 2.29% | 0.29% | 1.18% |
Dividend Yield | 2.69% | 2.54% | 1.88% | 1.64% | 1.31% | 0.92% |
Payout Ratio | 48.88% | 35.83% | 89.72% | 33.62% | 42.35% | 20.51% |
Buyback Yield / Dilution | 2.87% | 1.80% | -14.50% | -0.50% | -0.00% | 0.10% |
Total Shareholder Return | 5.56% | 4.33% | -12.62% | 1.14% | 1.31% | 1.01% |